254 related articles for article (PubMed ID: 1972036)
1. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
Zenke M; Muñoz A; Sap J; Vennström B; Beug H
Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
[TBL] [Abstract][Full Text] [Related]
2. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Rascle A; Ferrand N; Gandrillon O; Samarut J
Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
[TBL] [Abstract][Full Text] [Related]
3. A subpopulation of the avian erythroblastosis virus v-erbA protein, a member of the nuclear hormone receptor family, is glycosylated.
Privalsky ML
J Virol; 1990 Jan; 64(1):463-6. PubMed ID: 1967151
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of the v-erbA protein is required for its function as an oncogene.
Glineur C; Zenke M; Beug H; Ghysdael J
Genes Dev; 1990 Oct; 4(10):1663-76. PubMed ID: 1979040
[TBL] [Abstract][Full Text] [Related]
5. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action.
Schroeder C; Gibson L; Zenke M; Beug H
Oncogene; 1992 Feb; 7(2):217-27. PubMed ID: 1347914
[TBL] [Abstract][Full Text] [Related]
6. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
7. The v-erbA oncogene requires cooperation with tyrosine kinases to arrest erythroid differentiation induced by ligand-activated endogenous c-erbA and retinoic acid receptor.
Schroeder C; Gibson L; Beug H
Oncogene; 1992 Feb; 7(2):203-16. PubMed ID: 1347913
[TBL] [Abstract][Full Text] [Related]
8. v-erbA specifically suppresses transcription of the avian erythrocyte anion transporter (band 3) gene.
Zenke M; Kahn P; Disela C; Vennström B; Leutz A; Keegan K; Hayman MJ; Choi HR; Yew N; Engel JD
Cell; 1988 Jan; 52(1):107-19. PubMed ID: 2830979
[TBL] [Abstract][Full Text] [Related]
9. A single point mutation in erbA restores the erythroid transforming potential of a mutant avian erythroblastosis virus (AEV) defective in both erbA and erbB oncogenes.
Damm K; Beug H; Graf T; Vennström B
EMBO J; 1987 Feb; 6(2):375-82. PubMed ID: 2884103
[TBL] [Abstract][Full Text] [Related]
10. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
[TBL] [Abstract][Full Text] [Related]
11. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
12. Sequence-specific DNA binding by the v-erbA oncogene protein of avian erythroblastosis virus.
Bonde BG; Privalsky ML
J Virol; 1990 Mar; 64(3):1314-20. PubMed ID: 1968105
[TBL] [Abstract][Full Text] [Related]
13. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function.
Bonde BG; Sharif M; Privalsky ML
J Virol; 1991 Apr; 65(4):2037-46. PubMed ID: 1672166
[TBL] [Abstract][Full Text] [Related]
14. Biological effects of the v-erbA oncogene in transformation of avian erythroid cells.
Vennström B; Beug R; Damm K; Engel D; Gehring U; Graf T; Muñoz A; Sap J; Zenke M
Horm Metab Res Suppl; 1987; 17():14-9. PubMed ID: 2895057
[No Abstract] [Full Text] [Related]
15. The thyroid hormone receptor functions as a ligand-operated developmental switch between proliferation and differentiation of erythroid progenitors.
Bauer A; Mikulits W; Lagger G; Stengl G; Brosch G; Beug H
EMBO J; 1998 Aug; 17(15):4291-303. PubMed ID: 9687498
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
Selmi S; Samuels HH
J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
[TBL] [Abstract][Full Text] [Related]
17. c-ErbA, but not v-ErbA, competes with a putative erythroid repressor for binding to the carbonic anhydrase II promoter.
Rascle A; Ghysdael J; Samarut J
Oncogene; 1994 Oct; 9(10):2853-67. PubMed ID: 7916146
[TBL] [Abstract][Full Text] [Related]
18. Requirement for the C-terminal domain of the v-erbA oncogene protein for biological function and transcriptional repression.
Forrest D; Muñoz A; Raynoschek C; Vennström B; Beug H
Oncogene; 1990 Mar; 5(3):309-16. PubMed ID: 1969136
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional repression of band 3 and CAII in v-erbA transformed erythroblasts accounts for an important part of the leukaemic phenotype.
Fuerstenberg S; Leitner I; Schroeder C; Schwarz H; Vennström B; Beug H
EMBO J; 1992 Sep; 11(9):3355-65. PubMed ID: 1354613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
